<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Generalist Large Language Models Outperform Clinical Tools on Medical Benchmarks - Health AI Hub</title>
    <meta name="description" content="This paper reveals that state-of-the-art generalist Large Language Models (LLMs) consistently outperform specialized clinical AI tools on medical benchmarks, ch">
    <link rel="icon" type="image/svg+xml" href="../favicon.svg">
    <link rel="icon" type="image/png" sizes="32x32" href="../favicon-32x32.png">
    <link rel="icon" type="image/png" sizes="16x16" href="../favicon-16x16.png">
    <link rel="stylesheet" href="../styles.css">
</head>
<body>
    <header>
        <div class="container">
            <div class="breadcrumb">
                <a href="../index.html">‚Üê Back to all papers</a>
                <a href="../index.html" class="home-btn">üè† Home</a>
            </div>
        </div>
    </header>

    <main class="container paper-detail">
        <article>
            <h1>Generalist Large Language Models Outperform Clinical Tools on Medical Benchmarks</h1>

            <div class="paper-metadata">
                <div class="meta-row">
                    <strong>arXiv ID:</strong> <a href="http://arxiv.org/abs/2512.01191v1" target="_blank">2512.01191v1</a>
                </div>
                <div class="meta-row">
                    <strong>Published:</strong> 2025-12-01
                </div>
                <div class="meta-row">
                    <strong>Authors:</strong> Krithik Vishwanath, Mrigayu Ghosh, Anton Alyakin, Daniel Alexander Alber, Yindalon Aphinyanaphongs, Eric Karl Oermann
                </div>
                <div class="meta-row">
                    <strong>Categories:</strong> cs.CL
                </div>
                <div class="meta-row">
                    <strong>Relevance Score:</strong> 1.00 / 1.00
                </div>
            </div>

            <div class="action-buttons">
                <a href="http://arxiv.org/abs/2512.01191v1" target="_blank" class="btn btn-primary">View on arXiv</a>
                <a href="https://arxiv.org/pdf/2512.01191v1" target="_blank" class="btn btn-primary">Download PDF</a>
            </div>

            <section class="paper-section">
                <h2>Summary</h2>
                <p class="summary-text">This paper reveals that state-of-the-art generalist Large Language Models (LLMs) consistently outperform specialized clinical AI tools on medical benchmarks, challenging the perception that specialized tools are inherently safer or more reliable. Using a 1,000-item mini-benchmark, generalist models, with GPT-5 leading, demonstrated superior performance compared to OpenEvidence and UpToDate Expert AI, which showed deficits in completeness, communication, context awareness, and safety reasoning.</p>
            </section>

            <section class="paper-section">
                <h2>Medical Relevance</h2>
                <p>This research is critically important for medicine as it directly evaluates the performance and safety implications of AI tools currently being integrated into clinical decision support, potentially influencing patient diagnosis, treatment, and overall care quality.</p>
            </section>

            
            <section class="paper-section">
                <h2>AI Health Application</h2>
                <p>The paper focuses on the evaluation and application of large language models (LLMs) and specialized clinical AI systems as tools for clinical decision support, medical diagnosis, triage, and interpretation of medical guidelines within healthcare settings.</p>
            </section>
            

            <section class="paper-section">
                <h2>Key Points</h2>
                <ul class="key-points">
                    
                    <li>Specialized clinical AI assistants are entering medical practice with limited independent, quantitative evaluation, creating an evidence gap.</li>
                    
                    <li>The study assessed two deployed clinical AI systems (OpenEvidence, UpToDate Expert AI) against three frontier generalist LLMs (GPT-5, Gemini 3 Pro, Claude Sonnet 4.5).</li>
                    
                    <li>A 1,000-item mini-benchmark combining MedQA (medical knowledge) and HealthBench (clinician-alignment) tasks was used for evaluation.</li>
                    
                    <li>Generalist LLMs consistently outperformed the specialized clinical tools across the benchmark.</li>
                    
                    <li>GPT-5 achieved the highest scores among all evaluated models, indicating its superior performance in medical contexts.</li>
                    
                    <li>Clinical tools (OpenEvidence, UpToDate) showed significant deficits in completeness, communication quality, context awareness, and systems-based safety reasoning.</li>
                    
                    <li>The findings underscore an urgent need for transparent, independent evaluation of clinical AI tools before their deployment in patient-facing workflows.</li>
                    
                </ul>
            </section>

            <div class="two-column">
                <section class="paper-section">
                    <h2>Methodology</h2>
                    <p>The study utilized a quantitative evaluation approach, comparing the performance of five AI models on a 1,000-item 'mini-benchmark.' This benchmark integrated tasks from MedQA, assessing medical knowledge, and HealthBench, evaluating clinician-alignment. The models tested included two specialized clinical AI systems (OpenEvidence, UpToDate Expert AI) and three state-of-the-art generalist LLMs (GPT-5, Gemini 3 Pro, and Claude Sonnet 4.5).</p>
                </section>

                <section class="paper-section">
                    <h2>Key Findings</h2>
                    <p>The primary finding was that generalist LLMs consistently and significantly outperformed the specialized clinical AI tools. Specifically, GPT-5 achieved the highest scores across the combined MedQA and HealthBench tasks. In contrast, the specialized clinical tools, OpenEvidence and UpToDate Expert AI, demonstrated notable deficits in critical areas such as response completeness, communication quality, context awareness, and systems-based safety reasoning.</p>
                </section>
            </div>

            <section class="paper-section">
                <h2>Clinical Impact</h2>
                <p>These findings have a profound clinical impact, suggesting that currently deployed specialized clinical AI tools may be less reliable and potentially less safe than frontier generalist LLMs for tasks like diagnosis and guideline interpretation. This mandates a re-evaluation of current deployment strategies and emphasizes the critical need for rigorous, independent, and transparent validation of all AI systems before their integration into patient-facing clinical workflows to ensure optimal patient outcomes and safety.</p>
            </section>

            
            <section class="paper-section">
                <h2>Limitations</h2>
                <p>The abstract does not explicitly state limitations, but implicitly, the evaluation was conducted using a '1,000-item mini-benchmark,' which, while robust, may not cover the full breadth and complexity of all real-world clinical scenarios. The study's scope was limited to two specific clinical AI tools and three particular generalist LLMs.</p>
            </section>
            

            
            <section class="paper-section">
                <h2>Future Directions</h2>
                <p>The paper strongly advocates for an 'urgent need for transparent, independent evaluation' of clinical AI tools. This implies a future direction focused on establishing robust and continuous independent evaluation frameworks for all AI systems intended for deployment in patient-facing workflows, to ensure their safety, reliability, and effectiveness.</p>
            </section>
            

            <section class="paper-section">
                <h2>Medical Domains</h2>
                <div class="tags">
                    
                    <span class="tag">General Medicine</span>
                    
                    <span class="tag">Clinical Decision Support</span>
                    
                    <span class="tag">Medical Informatics</span>
                    
                    <span class="tag">Diagnosis</span>
                    
                    <span class="tag">Triage</span>
                    
                    <span class="tag">Guideline Interpretation</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Keywords</h2>
                <div class="tags">
                    
                    <span class="tag tag-keyword">Large Language Models (LLMs)</span>
                    
                    <span class="tag tag-keyword">Clinical AI Tools</span>
                    
                    <span class="tag tag-keyword">Medical Benchmarks</span>
                    
                    <span class="tag tag-keyword">Clinical Decision Support</span>
                    
                    <span class="tag tag-keyword">AI Evaluation</span>
                    
                    <span class="tag tag-keyword">Patient Safety</span>
                    
                    <span class="tag tag-keyword">Medical Knowledge</span>
                    
                    <span class="tag tag-keyword">GPT-5</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Abstract</h2>
                <p class="abstract">Specialized clinical AI assistants are rapidly entering medical practice, often framed as safer or more reliable than general-purpose large language models (LLMs). Yet, unlike frontier models, these clinical tools are rarely subjected to independent, quantitative evaluation, creating a critical evidence gap despite their growing influence on diagnosis, triage, and guideline interpretation. We assessed two widely deployed clinical AI systems (OpenEvidence and UpToDate Expert AI) against three state-of-the-art generalist LLMs (GPT-5, Gemini 3 Pro, and Claude Sonnet 4.5) using a 1,000-item mini-benchmark combining MedQA (medical knowledge) and HealthBench (clinician-alignment) tasks. Generalist models consistently outperformed clinical tools, with GPT-5 achieving the highest scores, while OpenEvidence and UpToDate demonstrated deficits in completeness, communication quality, context awareness, and systems-based safety reasoning. These findings reveal that tools marketed for clinical decision support may often lag behind frontier LLMs, underscoring the urgent need for transparent, independent evaluation before deployment in patient-facing workflows.</p>
            </section>

            
            <section class="paper-section">
                <h2>Comments</h2>
                <p>17 pages, 4 figures (2 regular, 2 supplemental)</p>
            </section>
            

            
        </article>
    </main>

    <footer class="container">
        <p><a href="../index.html">‚Üê Back to all papers</a></p>
    </footer>
</body>
</html>